Comparative Study of Pharmaceutical Costs in Iran's Insurance Systems: Review of National Data in an International Perspective
سال انتشار: 1393
نوع سند: مقاله ژورنالی
زبان: انگلیسی
مشاهده: 853
فایل این مقاله در 9 صفحه با فرمت PDF قابل دریافت می باشد
- صدور گواهی نمایه سازی
- من نویسنده این مقاله هستم
استخراج به نرم افزارهای پژوهشی:
شناسه ملی سند علمی:
JR_IJMR-1-3_005
تاریخ نمایه سازی: 4 خرداد 1395
چکیده مقاله:
Introduction: Medications are the substantial part of health carewith high costeffectivenessthat a large share of the household expenditure is allocated to them. Inrecent years, most developed countries have been faced with increasing Pharmaceuticalcosts (about 10%-20%). In recent years, Iran's Pharmaceutical costs also have constantlyincreased. The aim of this study was to evaluate Pharmaceutical coverage, determinePharmaceutical problems and find ways to overcome the problems.Methods: This study was a comparative-descriptive, review and retrospective study thatused library and internet sites as resources. The study has two major phases. In the firstphase, we searched primary sources and the internet to find an appropriate model togather information about Pharmaceutical systems in the selected countries. In the secondphase, we collected the information and statistics relating to pharmaceuticuse inoutpatients and inpatients from 1994 to 2011 which was formally received from 4 Iranianhealth insurance organizations.Results: The results show that the costs of pharmaceutical agencies at four main healthinsurance organizations in Iran had increased more than 722% between 2001-2011, whilein the leading countries specific mechanisms have been used to control Pharmaceuticalcosts in the healthcare.Conclusion: According to the findings of this review, different countries, especiallydeveloped countries have organized concepts such as new Pharmaceutical pricing,hospital Pharmaceuticals, over the counter (OTC) Drugs, control of Pharmaceutical use,patients share in the costs and etc which has controlled the pricing of the pharmaceuticalproducts in their societies. Therefore, in all countries, these programs are orientedtowards developing Pharmaceutical services, reducing the Pharmaceutical costs and therational control of Pharmaceutical use in terms of the framework of the health caresystem. In reviewing the insurance systems and its current policy in Iran, the evidencesrelating to the methods and structures cited above can be seen, but in practice, manydesigned processes are not applying or are implemented incompletely. GrowingPharmaceutical costs in Iran indicate this issue.
کلیدواژه ها:
نویسندگان
Shahram Tofighi
Dept. of Health Care Management, Schoolof Health, Baqiyatallah University of MedicalSciences, Tehran, Iran
Seyyed Hesamoddin Sharifinia
Pharmacoeconomic and Management, School of Pharmacy, Shahid Beheshti University of Medical Sciences, Tehran, Iran
Ali Hassanzadeh
Chairman of Iran Health Insurance Organization, Tehran, Iran
Farshad Najafipour
Aja University of Medical Sciences, CEO of Armed Forces Medical Insurance Organization, Tehran, Iran